2020
DOI: 10.4155/tde-2020-0069
|View full text |Cite
|
Sign up to set email alerts
|

The Potential Role of Nanomedicine on COVID-19 Therapeutics

Abstract: Although it is well-established that nanotech-based drug-delivery systems improve existing therapeutics in medicine, its application in viral diseases is underexplored and underused "

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
49
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(49 citation statements)
references
References 20 publications
0
49
0
Order By: Relevance
“…These strategies contribute to rapid diagnosis and isolation and may facilitate the treatment of people infected with SARS-CoV-2. The interactions between nanomaterials and biological interfaces are the basis for their potential (bio)medical applications (Mainardes and Diedrich, 2020).…”
Section: Nano Insights Into Diagnosis Treatment and Prevention Of Cmentioning
confidence: 99%
See 1 more Smart Citation
“…These strategies contribute to rapid diagnosis and isolation and may facilitate the treatment of people infected with SARS-CoV-2. The interactions between nanomaterials and biological interfaces are the basis for their potential (bio)medical applications (Mainardes and Diedrich, 2020).…”
Section: Nano Insights Into Diagnosis Treatment and Prevention Of Cmentioning
confidence: 99%
“…In COVID-19 therapy, nanotechnology has broad applications and can act in different stages of the disease, with the potential to inhibit virus-cell interaction, membrane fusion, cell internalization, transcription, translation, and viral replication, in addition to activating intracellular mechanisms that cause irreversible damage to viruses (Mainardes and Diedrich, 2020).…”
Section: Nanotechnologies In the Treatment Of Covid-19mentioning
confidence: 99%
“…Kenya: The first reported case of SARS-CoV-2 sequencing and analysis in Kenya consisted of positive samples from symptomatic and asymptomatic patients from Nairobi (20) and Coastal Kenya (102). Seventyeight global sequences representing countries in Europe, Asia, America and Africa in GISAID were randomly sampled and retrieved.…”
Section: Sars-cov-2 Genome Analysis Of African Isolatesmentioning
confidence: 99%
“…age, specimen source and status), gender served as a compulsory criterion for profiling the excavated genomes. Male isolates excavated according to Country (number of sequence, state(s) extracted), include: Algeria (2, 1); Benin (5, 2); Cameroon (1, 1); DRC (15,4); Egypt (5, 2); Gambia (6, 2); Ghana (4, 1); Kenya (4, 1); Mali (5, 2); Morocco (5, 3); Nigeria (13,5); Senegal (14,6); South Africa (65,20); Tunisia (1, 1). Female isolates excavated according to country (number of sequence, state(s) extracted), include: Algeria (1, 1); Benin (4, 1); DRC (13,4); Egypt (4, 2); Gambia (4, 2); Ghana (4, 1); Kenya (4, 1); Madagascar (2, 2); Mali (4, 1); Morocco (2, 1); Nigeria (11,5); Senegal (11,3); South Africa (80, 24); Tunisia (1, 1).…”
Section: Data Source and Genome Sequences Selectionmentioning
confidence: 99%
“…; Benin(5,2); Cameroon (1, 1); DRC(15,4); Egypt (5, 2); Gambia(6,2); Ghana (4, 1); Kenya (4, 1); Mali(5,2); Morocco(5,3); Nigeria(13,5); Senegal(14,6); South Africa(65,20); Tunisia (1, 1).Female isolates excavated according to country (number of sequence, state(s) extracted), include: Algeria (1, 1); Benin (4, 1); DRC(13,4); Egypt (4, 2); Gambia (4, 2); Ghana (4, 1); Kenya (4, 1); Madagascar (2, 2); Mali (4, 1); Morocco (2, 1); Nigeria(11,5); Senegal(11,3); South Africa (80, 24); Tunisia (1, 1). Hence, a total of 290 genome sequences (145 males, 145 females) with genome lengths of over 29000 nucleotides, were excavated.Specimen sources include swabs (nasal, oral, throat, nasal and oral); fluids (bronchoalveolar lavage, saliva, sputum) and unknown.…”
mentioning
confidence: 99%